Johan Sandell

发表

[18F]AZD4694 - A new PET radioligand for sensitive detection of β-amyloid deposits

Fredrik Jeppsson, Christer Halldin, Lars Farde, 2010, NeuroImage.

Path monitoring in optical transmission systems

Johan Sandell, Sven Wingstrand, Magnus Öberg, 1999 .

Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

Denis Guilloteau, Christer Halldin, Patrick Emond, 2001 .

Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand (11C)raclopride from (11C)methyl triflate

Christer Halldin, Kjell Någren, Johan Sandell, 1999 .

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

Lars Farde, Britt-Marie Swahn, Johan Sandell, 2010, Journal of neurochemistry.

Improved specific radioactivity of the PET radioligand [11C]FLB 457 by use of the GE medical systems PETtrace MeI microlab

Christer Halldin, Johan Sandell, Oliver Langer, 2000 .

A novel principle of radiotracer administration in human brain mapping: pet studies on brain uptake and distribution of orally and intravenously administered [11C]vinpocetine

Christer Halldin, Lars Farde, Per Karlsson, 2001, NeuroImage.

Improved syntheses of the PET radioligands, [11C]FLB 457, [11C]MDL 100907 and [11C]β‐CIT‐FE, by the use of [11C]methyl triflate

Victor W. Pike, Christer Halldin, Kjell Någren, 1998 .

Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies.

Bengt Långström, Johan Sandell, Mats Bergström, 2005, Nuclear medicine and biology.

AZD2184: a radioligand for sensitive detection of β‐amyloid deposits

Lars Farde, Johan Sandell, David Wensbo, 2009, Journal of neurochemistry.

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients

Christer Halldin, Lars Farde, Katarina Varnäs, 2013, European Journal of Nuclear Medicine and Molecular Imaging.